Bionano Genomics, Inc. (BNGO) vs Pasithea Therapeutics Corp. (KTTA)
A side-by-side comparison of Bionano Genomics, Inc. and Pasithea Therapeutics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNGO
Bionano Genomics, Inc.
$1.44HealthcareDelayed quote: Oct 6, 2026, 10:09 AM EDT
KTTA
Pasithea Therapeutics Corp.
$0.46HealthcareDelayed quote: Oct 6, 2026, 10:09 AM EDT
Total return — BNGO vs KTTA
growth of $100 · dividends reinvested · last 5yBNGO -100.0% (-78.5%/yr)KTTA -99.4% (-63.6%/yr)KTTA compounded faster over this window
Log scale — wide-divergence pair
BNGO KTTA
BNGO vs KTTA: by the numbers
- •BNGO is the larger company ($17M vs $15M market cap).
- •Both run net losses; KTTA's is the smaller (0.00% vs -106.58% net margin).
Metrics side by side
Valuation
| Metric | BNGO | KTTA |
|---|---|---|
| P/S ratio | 0.55 | N/A |
| P/B ratio | 0.52 | 0.31 |
Profitability
| Metric | BNGO | KTTA |
|---|---|---|
| Gross margin | 21.95% | 0.00% |
| Operating margin | -116.95% | 0.00% |
| Net margin | -106.58% | 0.00% |
| ROE | -101.76% | -42.72% |
| ROIC | -85.72% | -48.04% |
Growth (annualized)
| Metric | BNGO | KTTA |
|---|---|---|
| Revenue CAGR (5Y) | 17.97% | N/A |
| Total return CAGR (5Y) | -78.37% | -61.48% |
Frequently asked
- How have BNGO and KTTA total returns compared?
- Over the past 5 years, BNGO delivered -78.37% and KTTA delivered -61.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bionano Genomics ROEPasithea Therapeutics ROEBionano Genomics operating marginPasithea Therapeutics operating marginBionano Genomics revenue growthPasithea Therapeutics revenue growthBionano Genomics free cash flowPasithea Therapeutics free cash flow
Bionano Genomics & Pasithea Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.